PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsinfectious arthritis
MeSH D001170 - infectious arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D007239:Infections
2 Companies
2 Drugs
$
Success rate
D001168:Arthritis
15 Companies
8 Drugs
$
Success rate
D001170: 
Infectious arthritis
37 Companies
7 Drugs
$
Success rate
D016918:Reactive arthritis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCiprofloxacin Ciprofloxacin  2004-06-09   
Taro PharmaceuticalCiprofloxacin Ciprofloxacin  2004-10-06   
NATCO PharmaCiprofloxacin Ciprofloxacin  2004-06-09   
BayerCiprofloxacin Cipro  1987-10-22   
Aurobindo PharmaCiprofloxacin Ciprofloxacin  2007-04-26   
Barr PharmaceuticalsCiprofloxacin Ciprofloxacin  2004-06-09   
Dr Reddys LaboratoriesCiprofloxacin Ciprofloxacin  2004-06-09   
Dexamethasone, Ciprofloxacin Ciprofloxacin Dexamethasone  2020-08-10   
Rising PharmaceuticalsCiprofloxacin Ciprofloxacin  2004-06-09   
Sun Pharmaceutical IndustriesCiprofloxacin Ciprofloxacin  2004-06-09   
Dexamethasone, Ciprofloxacin Ciprofloxacin Dexamethasone  2022-08-30   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
50%
1/2
Phase 2
0%
0/0
Phase 3
100%
2/2
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
Cilastatin,
Imipenem,
Relebactam
Bayer
Ciprofloxacin
Dr Reddys Laboratories
Ciprofloxacin,
Dexamethasone
Sun Pharmaceutical Industries
Dexamethasone
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use